In the era of Corona, awareness has increased among the people about their health. A large number of people in India are resorting to Ayurvedic medicines and products to increase the body’s immunity and treat diseases. Therefore, the revenue of top Ayurvedic medicine and product companies of the country has increased. Dabur India is also included in these top companies. Brokerage firm Edelweiss says that its BUY rating given to Dabur remains intact. This rating is given on five bases.1. The company’s juices and out-of-home product categories have seen a good recovery. 2. Efforts are being made to introduce natural templates very strongly in products like shampoos and toothpastes. 3, The market share has increased in every portfolio of the company. 4. Product innovation continues and 5The company’s e-commerce business is growing. It has become 7 percent of its business.
Dabur India is in the top tier by volume
In the second quarter of FY 2021-22 also, Dabur remains in the top tier in terms of volume growth. In the last few quarters, it has remained among the top companies in terms of volume growth (due to Corona). In the case of major Ayurvedic products (of the company), the volume growth has reached 28 percent. However, currency volatility can be a risk for the company. The company’s business in Turkey may also be at risk from this. However, on the basis of these positives of the company, its BUY rating has been retained and its target price has been kept at Rs 720.
Star Health IPO: IPO of Rakesh Jhunjhunwala invested cold response in gray market, should you invest?
Share target price Rs 720
According to brokerage firm Edelweiss, Dabur’s performance is getting better in terms of rural growth. While the growth of its health and immunity-based products has been modest, it will be compensated by the growth in sales of its products in the food, beverage, personal care, skin and salon segments. The market share of its products in the oral care and OTC segment is increasing. Edelweiss says that currency volatility may pose some risk in its international business, especially in Turkey. But at present the company is showing strong growth and its share can be bought with a target price of Rs 720.
Get Business News ,, latest India News ,, and other breaking news on share market, investment scheme and much more on Business Khabar. Like us on Facebook, Follow us on Twitter for latest financial news and share market updates.
.